Publications of Esther Castillo-Gomez

Castillo-Gomez, E.; Oliveira, B.; Tapken, D.; Bertrand, S.; Klein-Schmidt, C.; Pan, H.; Zafeiriou, P.; Steiner, J.; Jurek, B.; Trippe, R. et al.; Prüss, H.; Zimmermann, W.-H.; Bertrand, D.; Ehrenreich, H.; Hollmann, M.: All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Molecular Psychiatry 22 (12), pp. 1776 - 1784 (2017)

Ehrenreich, H.; Castillo-Gomez, E.; Oliveira, B.; Ott, C.; Steiner, J.; Weissenborn, K.: Circulating NMDAR1 autoantibodies of different immunoglobulin classes modulate evolution of lesion size in acute ischemic stroke. Neurology, Psychiatry and Brain Research 22 (1), pp. 8 - 10 (2016)

Castillo-Gomez, E.; Kästner, A.; Steiner, J.; Schneider, A.; Hettling, B.; Poggi, G.; Ostehr, K.; Uhr, M.; Asif, A. R.; Matzke, M. et al.; Schmidt, U.; Pfander, V.; Hammer, C.; Schulz, T. F.; Binder, L.; Stöcker, W.; Weber, F.; Ehrenreich, H.: The brain as 'immunoprecipitator' of serum autoantibodies against N-Methyl-D-Aspartate receptor subunit NR1. Annals of Neurology 79 (1), pp. 144 - 151 (2016)

Castillo-Gomez, E.; Ehrenreich, H.: Response to letter regarding article "Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke". Stroke 46 (7), e178 (2015)